// App-Quantinova.ai

79 : POLYMORPHISMS IN SOCS 1 AND 3 AND HUMAN CORONARY ARTERY DISEASE

Researchers

Presenter

  • J. Marti-Jaun

Principal Investigators

  • M. Buehler

  • M. Herova

  • M. Hersberger

Medical Centers

  • Clinical Chemistry and Biochemistry, University Childrens Hospital, Zurich, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • High sensitivity C-reactive protein

  • Suppressor Of Cytokine Signaling 3

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final